Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission:a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial
- Breems, DA
- Boogaerts, MA
- Dekker, AW
- Van Putten, WLJ
- Sonneveld, P
- Huijgens, PC
- Van der Lelie, J
- Vellenga, E
- Gratwohl, A
- Verhoef, GEG
- Verdonck, LF
- Lowenberg, B
Publication date
January 2005
DOIAbstract
The question as to whether autologous stem cell transplantation (SCT) after consolidation chemotherapy improves the probability of survival of patients with acute myeloid leukaemia (AML) in first remission has not been settled. Here, we present the results of a phase III study conducted in newly diagnosed adult AML patients aged</p
Add to ORKG